Skip to main content
Veterinary Medicines

Fatroximin Topic Spray 0,294 g/100 g aerozol na skórę, roztwór

Authorised
  • Rifaximin

Product identification

Medicine name:
Fatroximin Topic Spray 0,294 g/100 g aerozol na skórę, roztwór
Active substance:
  • Rifaximin
Target species:
  • Cattle
  • Sheep
  • Goat
  • Horse
  • Cat
  • Pig
  • Rabbit
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Rifaximin
    0.50
    gram(s)
    /
    142.00
    gram(s)
Pharmaceutical form:
  • Cutaneous spray, solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Horse
      • Meat and offal
        0
        day
    • Cat
    • Pig
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD06AX11
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1042
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."